Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. 1977

A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004988 Ethers, Cyclic Compounds of the general formula R-O-R arranged in a ring or crown formation. Cyclic Ether,Cyclic Ethers,Ether, Cyclic
D001580 Benzopyrenes A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it. Benzpyrene
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
January 1979, Cancer research,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
August 1980, Proceedings of the National Academy of Sciences of the United States of America,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
November 1978, Proceedings of the National Academy of Sciences of the United States of America,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
November 1976, Cancer letters,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
October 1976, Proceedings of the National Academy of Sciences of the United States of America,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
November 1985, Cancer research,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
March 1977, Journal of the American Chemical Society,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
July 1977, Journal of the American Chemical Society,
A W Wood, and R L Chang, and W Levin, and H Yagi, and D R Thakker, and D M Jerina, and A H Conney
April 1979, Cancer letters,
Copied contents to your clipboard!